Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CCL25 mediates the localization of recently activated CD8αβ+ lymphocytes to the small-intestinal mucosa
Marcus Svensson, Jan Marsal, Anna Ericsson, Laura Carramolino, Therese Brodén, Gabriel Márquez, William W. Agace
Marcus Svensson, Jan Marsal, Anna Ericsson, Laura Carramolino, Therese Brodén, Gabriel Márquez, William W. Agace
View: Text | PDF
Article Aging

CCL25 mediates the localization of recently activated CD8αβ+ lymphocytes to the small-intestinal mucosa

  • Text
  • PDF
Abstract

Research Article

Authors

Marcus Svensson, Jan Marsal, Anna Ericsson, Laura Carramolino, Therese Brodén, Gabriel Márquez, William W. Agace

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Regulation of CCR9 expression on antigen-specific CD8αβ+ lymphocytes fol...
Regulation of CCR9 expression on antigen-specific CD8αβ+ lymphocytes following activation in vivo. (a) OT-1 (Ly5.2+) cells were injected into C57BL/6J-Ly5.1 mice, and their expression of CCR9 was determined by flow cytometry 3 days after intraperitoneal OVA administration. Numbers represent the percentage of OT-1 cells that are CCR9+ with background staining removed. Results are from one representative experiment of nine (MLN), seven (PLN), and two (spleen) experiments performed. (b) OT-1 cells from the MLNs of OVA-treated mice respond to CCL25. MLN and PLN lymphocytes were isolated 3 days after intraperitoneal administration of OVA, and the ability of OT-1 cells and endogenous CD8αβ+ lymphocytes to migrate to CCL25 (250 nM) was determined. Results are the mean ± SEM of four experiments with three mice per experiment. *P < 0.005.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts